TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/02/2026
Voltar para busca
Dado oficial do USPTO
HETSIFA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: Estados Unidos
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
55
Atualização mais recente
14/02/2026
Tipo de marca
Verbal
Classes Nice
1, 5
Data de depósito
03/07/2018
Data de registro
07/12/2021
Data de expiração
-
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
07/12/2021
Última transação
14/02/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
08/10/2021
Primeiro uso no comércio
08/10/2021
Código do desenho
4
Tipo de titular
03
Localização do titular
THE WOODLANDS, TX
Examinador
SOBRAL, CHRISTINA
Unidade examinadora
L90
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
FUZIONAIRE THERANOSTICS, INC.
Fuzionaire, Inc.
Representantes
John W. Peck KPPB LLP
Classificação técnica
Classes Nice
Classe 1Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
chemical preparations for scientific purposes; biochemicalbiologicalbiomarkerchemicaldiagnosticimaginglabellingtheranosticquantitation reagents and reagent kits comprised of biochemicalbiologicalbiomarkerchemicaldiagnosticimaginglabellingtheranosticquantitation reagents for scientific use for use in radiolabels for non-medical purposes; biochemicalbiologicalbiomarkerchemicaldiagnosticimaginglabellingtheranosticquantitation reagents and reagent kits comprised of biochemicalbiologicalbiomarkerchemicaldiagnosticimaginglabellingtheranosticquantitation reagents for scientific use for use in radiotracers for laboratory use; biochemicalbiologicalbiomarkerchemicaldiagnosticimaginglabellingtheranosticquantitation reagents and reagent kits comprised of biochemicalbiologicalbiomarkerchemicaldiagnosticimaginglabellingtheranosticquantitation reagents for scientific use for use in radiolabeled pharmaceutical candidates for non-medical laboratory evaluation and drug discovery purposes
Classe 5
Reagents and reagent kits comprised of biochemicalbiologicalbiomarkerchemicaldiagnosticimaginglabellingmedicaltheranostictherapeuticquantitation reagents for use in radiolabels and radiopharmaceuticals for medical or veterinary purposes; biochemicalbiologicalbiomarkerchemicaldiagnosticimaginglabellingmedicaltheranostictherapeuticquantitation reagents and reagent kits comprised of biochemicalbiologicalbiomarkerchemicaldiagnosticimaginglabellingmedicaltheranostictherapeuticquantitation reagents for use in radiopharmaceuticals for clinical medical and veterinary diagnostic purposes
Publicações
Histórico de despachos e eventos da marca no USPTO.
55 publicações encontradas
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/02/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/02/2026
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/12/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/12/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/12/2023
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
13/09/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
07/12/2021
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
04/11/2021
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
03/11/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
20/10/2021
SUPC
STATEMENT OF USE PROCESSING COMPLETE
19/10/2021
EX5G
SOU EXTENSION 5 GRANTED
19/10/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
19/10/2021
IUAF
USE AMENDMENT FILED
13/10/2021
EXT5
SOU EXTENSION 5 FILED
13/10/2021
EEXT
SOU TEAS EXTENSION RECEIVED
13/10/2021
EISU
TEAS STATEMENT OF USE RECEIVED
13/10/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/05/2021
EX4G
SOU EXTENSION 4 GRANTED
04/05/2021
EXT4
SOU EXTENSION 4 FILED
04/05/2021
EEXT
SOU TEAS EXTENSION RECEIVED
04/05/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/11/2020
EX3G
SOU EXTENSION 3 GRANTED
10/11/2020
EXT3
SOU EXTENSION 3 FILED
10/11/2020
EEXT
SOU TEAS EXTENSION RECEIVED
10/11/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/05/2020
EX2G
SOU EXTENSION 2 GRANTED
06/05/2020
EXT2
SOU EXTENSION 2 FILED
06/05/2020
EEXT
SOU TEAS EXTENSION RECEIVED
06/05/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
23/10/2019
EX1G
SOU EXTENSION 1 GRANTED
21/10/2019
EXT1
SOU EXTENSION 1 FILED
21/10/2019
EEXT
SOU TEAS EXTENSION RECEIVED
21/10/2019
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
21/05/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
26/03/2019
PUBO
PUBLISHED FOR OPPOSITION
26/03/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/03/2019
ALIE
ASSIGNED TO LIE
15/02/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/02/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/02/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
31/01/2019
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
31/01/2019
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
28/01/2019
GNFR
FINAL REFUSAL E-MAILED
28/01/2019
CNFR
FINAL REFUSAL WRITTEN
28/01/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/01/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/01/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/01/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
23/10/2018
GNRT
NON-FINAL ACTION E-MAILED
23/10/2018
CNRT
NON-FINAL ACTION WRITTEN
23/10/2018
DOCK
ASSIGNED TO EXAMINER
23/10/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/07/2018
NWAP
NEW APPLICATION ENTERED
06/07/2018
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace HETSIFA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.